Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 425

Similar articles for PubMed (Select 7665537)

1.

Bupropion: a review of its mechanism of antidepressant activity.

Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E, et al.

J Clin Psychiatry. 1995 Sep;56(9):395-401. Review.

PMID:
7665537
2.

Studies of bupropion's mechanism of antidepressant activity.

Ferris RM, Cooper BR, Maxwell RA.

J Clin Psychiatry. 1983 May;44(5 Pt 2):74-8. Review.

PMID:
6406468
3.

Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain.

El Mansari M, Ghanbari R, Janssen S, Blier P.

Neuropharmacology. 2008 Dec;55(7):1191-8. doi: 10.1016/j.neuropharm.2008.07.028. Epub 2008 Jul 30.

PMID:
18708076
5.

Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters.

Bandoh T, Hayashi M, Ino K, Takada S, Ushizawa D, Hoshi K.

Eur Neuropsychopharmacol. 2004 Dec;14(6):471-8.

PMID:
15589386
6.

Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.

Ogren SO, Kuteeva E, Hökfelt T, Kehr J.

CNS Drugs. 2006;20(8):633-54. Review.

PMID:
16863269
7.

Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism.

Cooper BR, Wang CM, Cox RF, Norton R, Shea V, Ferris RM.

Neuropsychopharmacology. 1994 Oct;11(2):133-41.

8.

Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profile.

Claustre Y, Leonetti M, Santucci V, Bougault I, Desvignes C, Rouquier L, Aubin N, Keane P, Busch S, Chen Y, Palejwala V, Tocci M, Yamdagni P, Didier M, Avenet P, Le Fur G, Oury-Donat F, Scatton B, Steinberg R.

Neuroscience. 2008 Oct 2;156(2):353-64. doi: 10.1016/j.neuroscience.2008.07.011. Epub 2008 Jul 11.

PMID:
18691638
9.

Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?

Adell A.

Curr Drug Targets CNS Neurol Disord. 2004 Apr;3(2):113-21. Review. Erratum in: Curr Drug Targets CNS Neurol Disord. 2004 Jun;3(3)269.

PMID:
15078186
11.
12.
13.
14.

Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation.

Manta S, Dong J, Debonnel G, Blier P.

J Psychiatry Neurosci. 2009 Jul;34(4):272-80.

15.
16.
17.

The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs.

O'Leary OF, Bechtholt AJ, Crowley JJ, Valentino RJ, Lucki I.

Eur Neuropsychopharmacol. 2007 Feb;17(3):215-26. Epub 2006 Sep 25.

PMID:
16997535
19.

Nicotine potentiates imipramine-induced effects on catecholamine metabolism: possible relation to antidepressant activity.

Antkiewicz-Michaluk L, Michaluk J, Romańska I, Popik P, Krawczyk M, Nalepa I, Vetulani J.

Pharmacol Rep. 2006 Nov-Dec;58(6):836-45.

20.

Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.

Dhir A, Kulkarni SK.

Eur J Pharmacol. 2007 Jul 30;568(1-3):177-85. Epub 2007 May 4.

PMID:
17509558
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk